HIGHLIGHTS
- who: Shao-Wei Feng et al. from the Department of Neurologic Surgery, Tri-Service General Hospital, National Defense Medical Center, Department of Biochemistry, National Defense Medical Center, Taipei, Taiwan have published the article: Exploring the Mechanism of Adjuvant Treatment of Glioblastoma Using Temozolomide and Metformin, in the Journal: (JOURNAL) of 15/01/2021
- what: The aim of this study is to investigate the mechanism of metformin as a potential adjuvant treatment drug in glioblastoma. The study showed that metformin decreased metabolic activity proliferation migration mitochondrial biogenesis and mitochondrial membrane potential and increased apoptosis and ROS . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.